Cargando…
Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer
SIMPLE SUMMARY: Aberrant Wnt/β-catenin signaling contributes to the development, progression, and metastasis of CRC, by altering target gene expression connected to cancer cell proliferation and motility. S100A4 is a Wnt/β-catenin target gene, which strongly enhances migration and invasion of CRC ce...
Autores principales: | Dahlmann, Mathias, Monks, Anne, Harris, Erik D., Kobelt, Dennis, Osterland, Marc, Khaireddine, Fadi, Herrmann, Pia, Kemmner, Wolfgang, Burock, Susen, Walther, Wolfgang, Shoemaker, Robert H., Stein, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750436/ https://www.ncbi.nlm.nih.gov/pubmed/35008201 http://dx.doi.org/10.3390/cancers14010037 |
Ejemplares similares
-
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis
por: Kortüm, Benedikt, et al.
Publicado: (2022) -
Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker
por: Schmid, Felicitas, et al.
Publicado: (2022) -
S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction
por: Dahlmann, Mathias, et al.
Publicado: (2016) -
High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients
por: Ilm, Katharina, et al.
Publicado: (2015) -
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
por: Kobelt, Dennis, et al.
Publicado: (2021)